United States News All stories

Quantum Corp. (NASDAQ:QMCO) announced select preliminary, unaudited financial results for its fiscal fourth quarter of 2026, highlighted by total revenue that is expected to come in significantly ahead of the company's previously issued guidance range.

INVO Fertility (NASDAQ:IVF) reported a 5% increase in total net revenue for fiscal year 2025, supported by steady expansion across its clinic network and a restructured balance sheet that eliminated several complex legacy equity liabilities.

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vanderbilt Health announced that a Phase 2a clinical trial evaluating the investigational drug ifetroban successfully met its primary endpoint, demonstrating safety and tolerability in patients with high-risk solid tumors.

Castor Maritime (NASDAQ:CTRM) reported a significant turnaround in its financial performance for the first quarter of 2026, driven by steady operational growth and substantial non-operating gains from its investment holdings.

Legend Biotech (NASDAQ:LEGN) announced encouraging initial clinical data from an ongoing Phase 1 study evaluating LB2501, its experimental in vivo CD19/CD20 dual-targeting CAR-T therapy, for the treatment of patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

The Buckle (NYSE:BKE) announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per share, sustaining the retail company's program of regular distributions to its public investors.

Voyager Technologies (NYSE:VOYG) has signed a definitive agreement to acquire Astrobotic Technology, a privately held developer of commercial lunar delivery systems, surface power infrastructure, and reusable rockets.

Vera Therapeutics (NASDAQ:VERA) has reached an agreement with the U.S. Food and Drug Administration to accelerate the regulatory timeline for its experimental kidney disease treatment, clearing the path for an earlier analysis of pivotal Phase 3 data.

BeyondSpring (NASDAQ:BYSI) announced updated data from an investigator-initiated Phase 2 clinical trial evaluating a triple-combination therapy for patients with advanced lung cancer, demonstrating sustained overall survival and disease control in a difficult-to-treat population.

Saia (NASDAQ:SAIA) reported solid expansion across its core less-than-truckload (LTL) operational metrics for April and May 2026, driven by an acceleration in daily tonnage and ongoing improvements in freight weight profiles compared to the prior year.

Village Super Market (NASDAQ:VLGEA) reported a 1.6% increase in net sales for its fiscal 2026 third quarter, as resilient grocery demand and robust digital growth helped mitigate the operational disruptions caused by severe winter weather.

Victoria’s Secret (NYSE:VSCO) reported a 15% increase in first-quarter net sales, fueled by a sharp recovery in consumer demand that prompted the apparel retailer to lift its financial projections for the full fiscal year.

Watsco (NYSE:WSO) has finalized its acquisition of Jackson Supply Company, a prominent distributor of heating, ventilation, and air conditioning (HVAC) equipment, significantly expanding its operational reach across the fast-growing U.S. Sunbelt region.

Evogene (NASDAQ:EVGN) announced that a first-in-human Phase 1 clinical trial evaluating its experimental microbiome-based oncology therapy, BMC128, successfully met its primary safety endpoint when administered in combination with the immunotherapy drug Nivolumab.

Camtek (NASDAQ:CAMT) announced it has received more than $105 million in new multi-system orders for its semiconductor inspection and metrology equipment, extending the company’s business visibility well into the following year.

Travere Therapeutics (NASDAQ:TVTX) has entered into an exclusive licensing and collaboration agreement with Everest Medicines to develop and commercialize civorebrutinib, an experimental treatment targeting multiple immune-mediated rare kidney diseases.

Oddity Tech (NASDAQ:ODD) reported a 26% decline in first-quarter net revenue as a severe dislocation with its largest digital advertising partner drove customer acquisition costs sharply higher and eroded media efficiency.

Signet Jewelers (NYSE:SIG) announced total sales of $1.6 billion for the 13 weeks ended May 2, 2026, marking a steady recovery in consumer demand for fine jewelry.

Dollar General (NYSE:DG) reported its financial results for the first quarter of fiscal year 2026 ended May 1, 2026, delivering top-line revenue gains and a double-digit expansion in operating profitability.

Pasithea Therapeutics (NASDAQ:KTTA) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to its lead therapeutic candidate, PAS-004, for the treatment of Amyotrophic Lateral Sclerosis (ALS).

Genco Shipping & Trading (NYSE:GNK) announced that its Board of Directors has unanimously rejected a revised, unsolicited tender offer from Diana Shipping (NYSE:DSX).

Citi Trends (NASDAQ:CTRN), a leading off-price value retailer specializing in apparel, accessories, and home trends, reported a significant acceleration in its financial performance for the first quarter of fiscal 2026 ended May 2, 2026.

Yesway (NASDAQ:YSWY) reported record financial results for the first quarter of 2026, marking a sharp operational turnaround driven by expanding in-store sales and robust retail fuel performance.

SOLAI (NYSE:SLAI) has completed the acquisition of a 51 percent controlling stake in NEURALAND, a Singapore-based technology firm specializing in the design and manufacturing of personal artificial intelligence nodes.